Pregled bibliografske jedinice broj: 241758
Glycoscience-a new frontier in rational drug design
Glycoscience-a new frontier in rational drug design // Acta Pharmaceutica, 56 (2006), 19-30 (podatak o recenziji nije dostupan, pregledni rad, ostalo)
CROSBI ID: 241758 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Glycoscience-a new frontier in rational drug design
Autori
Gornik, Olga ; Dumic, Jerka ; Flogel, Mirna ; Lauc, Gordan
Izvornik
Acta Pharmaceutica (1330-0075) 56
(2006);
19-30
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, ostalo
Ključne riječi
glycoproteins; lectins; therapeutics
Sažetak
Glycans are the most abundant and most diverse biopolymers in nature. Because of their highly specific interactions with physiological receptors, they participate in many crucial biological processes. All these processes are potential targets for therapeutic intervention, and carbohydrate-based drugs are rapidly being taken up by the modern biotechnology and pharmaceutical industry. Recent developments in the field of glycobiology have overcome the problem of glycan analysis and synthesis ; and many compounds based on carbohydrates are now in various stages of clinical trials. This article presents glycoproteins in a new light, as an important biopharmaceutical targets, giving an overview of their potential use as therapeutic glycoproteins and proteoglycans, inflammation blockers, cancer therapeutics and vaccines, inhibitors of pathogenic microbes, viral inhibitors and potential aids in the treatment of lysosomal diseases, neurological diseases and transplantation rejection.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
0006611
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Olga Gornik Kljaić
(autor)
Gordan Lauc
(autor)
Jerka Dumić
(autor)
Mirna Flogel-Mršić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE